European Regulations DOUE Importance: 5/10

New EU regulation on microplastics: exceptions for medicines and research

02 Jun 2026 Effective: 02 Jun 2026 0 views
Who is affected:
Manufacturers, distributors and users of microplastic products; pharmaceutical and research sectors

Summary

The EU modifies restrictions on synthetic polymer microparticles (microplastics) to clarify exceptions for medicines, clinical trials and research. Conditions are also specified for products with microplastics encapsulated in solid matrices.

Detailed analysis PRO

Regulation (EU) 2026/1168 amends Annex XVII of the REACH Regulation to correct and expand exceptions to the ban on placing synthetic polymer microparticles on the market. The exemption for human and veterinary medicines is broadened, expressly including those used in clinical trials and preclinical safety testing. A ne…

PRO exclusive content

Implicaciones prácticas, plazos y recomendaciones específicas para tu sector.

Crear cuenta gratis Ver planes PRO

Full official title

OJ:L_202601168: Reglamento (UE) 2026/1168 de la Comisión, de 1 de junio de 2026, por el que se modifica el anexo XVII del Reglamento (CE) n.o 1907/2006 del Parlamento Europeo y del Consejo en lo relativo a las micropartículas de polímeros sintéticos

View original source (DOUE)

Affected sectors

Technology Healthcare Agriculture

Categories

Tax & Revenue Labour & Employment Corporate & Business Data Protection Social Security European Regulations Grants & Subsidies Other Regulations Public Sector Education Energy Agriculture & Fisheries Real Estate

PRO Plan

Alerts, detailed analysis and private Telegram channel.

From 9.99 EUR/month

Related regulations